Screener
Guardant Health GH Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Guardant Health in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Guardant Health’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 5:16 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001576280-26-000026
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenue | $301,665 | $203,471 |
| Costs and operating expenses: | ||
| Cost of revenue | 104,919 | 74,723 |
| Research and development expense | 91,038 | 88,521 |
| Sales and marketing expense | 169,132 | 104,316 |
| General and administrative expense | 57,926 | 46,952 |
| Total costs and operating expenses | 423,015 | 314,512 |
| Loss from operations | (121,350) | (111,041) |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Guardant Health's total revenue?
- Guardant Health (GH) reported total revenue of $301.67M in Q1 2026.
- How has Guardant Health's total revenue changed year-over-year?
- Guardant Health's total revenue increased by 48.3% year-over-year, from $203.47M to $301.67M.
- What is the long-term trend for Guardant Health's total revenue?
- Over 4 years (2021 to 2025), Guardant Health's total revenue has grown at a 27.3% compound annual growth rate (CAGR), from $373.65M to $982.02M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Guardant Health's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude